Dr Ralph George Menard Jr, MD in Fredericksburg, TX - Medicare

Dr Ralph George Menard Jr, MD is a medicare enrolled "Pain Medicine - Interventional Pain Medicine" physician in Fredericksburg, Texas. His current practice location is 205 W Windcrest St Ste 350, Fredericksburg, Texas. You can reach out to his office (for appointments etc.) via phone at (830) 990-1404.

Dr Ralph George Menard Jr is licensed to practice in Texas (license number H5592) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1407876014.

Contact Information

	Dr Ralph George Menard Jr, MD
	205 W Windcrest St Ste 350, Fredericksburg, TX 78624-4478
	(830) 990-1404
	Not Available

Physician's Profile

Full Name	Dr Ralph George Menard Jr
Gender	Male
Speciality
Experience	Years
Location	205 W Windcrest St Ste 350, Fredericksburg, Texas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Ralph George Menard Jr attended and graduated from in

NPI Data:

NPI Number: 1407876014
Provider Enumeration Date: 07/20/2006
Last Update Date: 06/28/2017

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Dr Ralph George Menard Jr such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1407876014	NPI	-	NPPES
130355404	Medicaid	TX
050012360	Other		MEDICARE RAILROAD BEFORE 5/27/08
00J04K	Other	TX	BLUE CROSS BLUE SHIELD
H5592	Other	TX	STATE LICENSE NUMBER
P00473907	Other		MEDICARE RAILROAD AFTER 5/27/08

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208VP0014X	Pain Medicine - Interventional Pain Medicine	H5592 (Texas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ralph George Menard Jr is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Ralph George Menard Jr, MD 205 W Windcrest St, Suite 130, Fredericksburg, TX 78624-4479 Ph: () -	Dr Ralph George Menard Jr, MD 205 W Windcrest St Ste 350, Fredericksburg, TX 78624-4478 Ph: (830) 990-1404

News Archive

Human testes respond differently to endocrine disrupting chemicals

Human and rat testes respond differently to endocrine disrupting chemicals such as BPA in two thirds of all cases, according to a recent review. As human safety levels are extrapolated from rodent data, the study could lead to a re-evaluation of the acceptable daily intake for many endocrine disruptors.

Tsuyama Chuo Hospital in Japan commences clinical use of RayStation

Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil beam scanning treatments at its Proton Beam Cancer Center. On 15 May, the center carried out the world's first patient treatment using RayStation together with Mitsubishi Electric's proton therapy system, with a plan created in RayStation 6.

Outcome of penile prosthesis implantation for treating erectile dysfunction

Nine out of ten men fitted with a penile prosthesis were able to have sexual intercourse and eight out of ten were satisfied with the overall results, according to research published in the latest issue of BJU International.

Genomics and proteomics to increase the efficiency of drug discovery and development

While the United Sates is still the world leader, Europe is having a good deal of success in the field of advanced genomics and proteomics research. Significant government funding together with the presence of large pharmaceutical companies has made Europe a major competitor in the efforts to deploy genomics and proteomics as vital tools in drug discovery and development.

FXR can slow proliferation of tamoxifen-resistant breast cancer cells: Study

A receptor that is present in the nucleus of cells can, when activated, slow the growth of tamoxifen-resistant breast cancer cells, a new study found. The study built on the recent discovery that farnesoid X receptor — a nuclear receptor found mainly in the liver — is found in breast cancer tissue.

Dr Ralph George Menard Jr, MD - Medicare in Fredericksburg, TX